U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301892) titled 'Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis' on Sept. 28.
Brief Summary: Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the diagnosis of various complications of rheumatoid arthritis (RA). In a retrospective study using RA patients' EHR records, we will quantify physician adoption of GenAI predictions for RA complications and co-existing diseases. In a prospective observational study, we will assess the feasibility of using GenAI predictions as additional clinical information to help p...